Tempus AI, Inc. TEM Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Clinical Order | $942.3M+89.4% | $884.5M+116% | $747.7M+95.0% | $617.5M+68.4% | $497.5M+42.4% | |
| Insights Product | $279.5M+36.3% | $257.7M+38.0% | $240.4M+49.3% | $221.5M+60.7% | $205M+62.4% | |
| Trials Product | $38.7M-5.4% | $38.5M-9.4% | $39.3M-14.6% | $40.2M-13.5% | $40.9M-12.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Tempus AI, Inc. break its business down?
- Tempus AI, Inc. (TEM) reports revenue by product across 6 parts — AI Applications, Clinical Order, Genomics Product, Insights Product and Next Product. Each is extracted from the segment footnotes and tracked over time.
- Where does Tempus AI, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Tempus AI, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
